Despite global headwinds, Liechtenstein has preserved high incomes, low unemployment, and a strong fiscal position. Yet, its ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today ...
Since 2000, real U.S. GDP growth has expanded at the slowest 25-year growth rate in U.S. history, despite profound ...
With the wrong architecture in place, AI algorithms can nudge biopharmaceutical developers toward unpredicted and misaligned ...
The new Form 48 replaces Form 3CEB and mandates reporting of international and domestic transactions. It enhances structured ...
In an age when the digital world often feels all consuming, a spam account is a form of self-care — an occupation that ...
The Allspring Diversified Income Builder Fund outperformed its benchmark in Q4 2025 amid global equity gains. Read the full ...
The study is a promising breakthrough that could eventually prove key to understanding the disease’s mysterious origins, its ...
Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...
Two new studies report improved statistics to predict whether an individual participated in a genome-wide association study based on aggregate allele or genotype frequency information. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results